3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
23
Carcinoma, Non-Small-Cell Lung
16
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
11
Carcinoma, Hepatocellular
10
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Mycosis Fungoides
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Thyroid Neoplasms
3
Sezary Syndrome
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Brenner Tumor
3
Brain Neoplasms
3
Interventions
Temozolomide
15
Radiotherapy
10
Radiation
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
5
Specimen Handling
5
Ipilimumab
3
atezolizumab
2
Photons
2
Nivolumab
2
Biopsy
2
veliparib
1
selinexor
1
sargramostim
1
plerixafor
1
peposertib
1
pazopanib
1
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
montanide ISA 51
1
liposomal doxorubicin
1
gosha-jinki-gan
1
fluorodopa F 18
1
ferric pyrophosphate
1
efineptakin alfa
1
cemiplimab
1
cabozantinib
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
Immunoglobulin G
×
1 year
×
Clear all
No trials found.